Welcome to our dedicated page for Lazard SEC filings (Ticker: LAZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lazard, Inc. filings document the regulatory record for a financial advisory and asset management company listed on the NYSE under LAZ. Form 8-K reports furnish quarterly and annual results, Regulation FD strategy updates, material agreements, executive officer changes, compensation arrangements, and other material-event disclosures tied to the firm’s advisory and asset management businesses.
Proxy materials cover board elections, governance practices, executive compensation and shareholder voting matters. The company’s risk-factor disclosures address conditions in global and regional financial markets, M&A activity, assets under management, liquidity, third-party exposures and competition, alongside capital-structure and reporting matters.
LAZ filed a Form 144 reporting insider sales. Reported sales by Mary A. Betsch total $557,273.08 in proceeds from two transactions: $496,112.53 for 12,121 shares sold on 03/17/2026 and $61,160.55 for 1,515 shares sold on 03/18/2026. The filing also lists Restricted Stock Vesting on 03/16/2026 for 1,515 shares described as compensation.
Farr Tracy reported acquisition or exercise transactions in this Form 4 filing.
Lazard, Inc. Chief Financial Officer Tracy Farr received a grant of 12,982 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. After this award, Farr holds 37,576 shares-equivalent RSUs directly.
The RSUs vest over three years, with 4,327 units scheduled to vest on or around March 1, 2027, another 4,327 on or around March 1, 2028, and 4,328 on or around March 1, 2029. This is a compensation-related equity award rather than an open-market stock purchase or sale.
Lazard, Inc. CEO and Chairman Peter Richard Orszag reported a combination of equity awards and share sales. On March 16, 2026, he exercised 138,340 Restricted Participation Units, receiving the same number of Lazard common shares at a conversion price of $0.00 per unit.
To cover estimated taxes from this exchange, he disposed of 41,502 shares to the company at an average price of $40.82 per share. On March 17, 2026, he conducted open-market sales totaling 69,170 shares at weighted-average prices of $40.7318 and $41.6593 per share, executed under a pre-arranged Rule 10b5-1 trading plan intended to cover estimated taxes and personal expenditures. Following these transactions, he directly owns 210,942 shares of Lazard common stock.
Soto Alexandra reported acquisition or exercise transactions in this Form 4 filing.
Lazard, Inc. Chief Operating Officer Alexandra Soto received a grant of 101,739 Restricted Stock Units, each representing a right to one share of common stock. These RSUs are scheduled to vest on or around March 1, 2029. Following this award, she holds 301,483 shares and units directly, underscoring that this filing reflects compensation rather than an open-market trade.
Gathy Michael reported acquisition or exercise transactions in this Form 4 filing.
Lazard, Inc. reported that Chief Accounting Officer Michael Gathy received a grant of 5,564 Restricted Stock Units, each representing one share of common stock. This award increases his directly held RSUs to 12,758. Portions of the grant are scheduled to vest in March 2027, March 2028, and March 2029.
LAZ filed a Section 144 notice reporting a proposed sale of 1,515 shares of Common Stock associated with restricted stock vesting on 03/16/2026. The filing also discloses a sale of 12,121 shares on 03/17/2026 for $496,112.53.
FMR LLC amended a Schedule 13G to report beneficial ownership of 11,260,412 shares, representing 10.1% of Lazard Inc. common stock. The filing shows FMR LLC holds sole dispositive power for 11,260,412 shares, and Abigail P. Johnson is reported with sole dispositive power for the same amount.
The amendment includes address and CUSIP details and references Exhibit 99 and powers of attorney; signatures were provided by Stephanie J. Brown on behalf of FMR LLC and Abigail P. Johnson.